Invention Application
- Patent Title: QUINAZOLINEDIONES AND THEIR USE
- Patent Title (中): 喹诺酮类及其用途
-
Application No.: US14004633Application Date: 2012-03-12
-
Publication No.: US20140031358A1Publication Date: 2014-01-30
- Inventor: Dong Liu , Minsheng Zhang , Kan He , Lianshan Zhang
- Applicant: Dong Liu , Minsheng Zhang , Kan He , Lianshan Zhang
- Applicant Address: US NJ Cranbury
- Assignee: Eternity Bioscience Inc.
- Current Assignee: Eternity Bioscience Inc.
- Current Assignee Address: US NJ Cranbury
- International Application: PCT/US12/28698 WO 20120312
- Main IPC: C07D239/96
- IPC: C07D239/96 ; C07D403/10 ; C07D487/04 ; C07D403/12 ; C07D405/12 ; C07D471/04 ; C07D401/10 ; C07D401/12 ; C07D401/14 ; C07D413/12
Abstract:
The present invention discloses compounds of formula (I), or pharmaceutically acceptable salts or prodrugs thereof, which inhibit the poly(ADP-ribose) polymerases (PARP) and therefore are useful for treating diseases, disorders, and conditions related to PARP. The present invention also discloses pharmaceutical compositions comprising a compound of formula (I), and methods of using such compounds to inhibit PARP enzymes, and to treat diseases, disorders, and conditions related to PARP.
Public/Granted literature
- US09090568B2 Quinazolinediones and their use Public/Granted day:2015-07-28
Information query
